Abstract

The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) often responsible for numerous hospital-associated outbreaks has become an important public health problem. From January 2013 to February 2014, a total of 41 non-duplicate K. pneumoniae isolates with carbapenem resistance, were collected at a tertiary teaching hospital in Nanchang, central China. Among 41 K. pneumoniae isolates, 28 were isolated from hospitalized patients including 19 from the patients in surgery intensive care unit (SICU) and 13 were isolated from ventilators. Twenty-four of 28 patients infected by CRKP have been submitted to mechanical ventilation using ventilator. More than 95% of the CRKP isolates were resistant to 13 antimicrobials tested. All CRKP isolates were confirmed as carbapenemase producer and were positive for blaKPC-2, with one positive for both blaKPC-2 and blaNDM-1. All carbapenemase-producing isolates harbored at least one of extended spectrum β-lactamase genes tested, among which 95.1% (39/41) of the tested isolates were found to harbor both blaCTX-M-24 and blaKPC-2, Of note, one isolate harbored simultaneously two carbapenemase genes (blaKPC-2 and blaNDM-1) and two ESBL genes (blaCTX-M-3 and blaTEM-104). To the best of our knowledge, coexistence of blaKPC-2 and blaCTX-M-24 in one isolate is first reported. MLST results showed that 41 CRKP isolates belonged to four sequence types (STs) including ST11, novel ST1854, novel ST1855, and ST1224. PFGE results displayed three PFGE clusters. Thirty-eight ST11 CRKP isolates (92.7%, 38/41) including all 13 isolates from ventilators and 25 isolates from patients from seven wards (18 from SICU) belonged to same PFGE cluster, indicating these isolates were clonally related. Fifteen isolates have an identical undistinguished pattern (100% similarity) forming a single clonal population. Moreover, this clone was exclusively linked to the cases attended in SICU and linked to the Ventilators. Additionally, the other SICU cases were linked to closely related clones (similarity greater than 95%). These data indicated that the occurrence of a clonal outbreak associated with ventilators has been found. In conclusion, outbreak by ventilator-associated ST11 K. pneumoniae with co-production of CTX-M-24 and KPC-2 is found in a SICU of a tertiary teaching hospital in central China.

Highlights

  • MATERIALS AND METHODSKlebsiella pneumoniae is an opportunistic pathogen associated mainly with pneumonia, bloodstream infections, and urinary tract infections

  • We demonstrated a outbreak by ventilator-associated ST11 K. pneumoniae with co-production of CTX-M-24 and K. pneumoniae carbapenemases (KPCs)-2

  • The result of the present study was similar to previous reports in which blaKPC−2 was the predominant carbapenemase gene among K. pneumoniae in China (Chen et al, 2011; Hu et al, 2012)

Read more

Summary

Introduction

MATERIALS AND METHODSKlebsiella pneumoniae is an opportunistic pathogen associated mainly with pneumonia, bloodstream infections, and urinary tract infections. Carbapenems are often used for the treatment of clinical infections caused by this clinically important pathogen with multi-resistance to antimicrobial agents. As frequently carry additional antimicrobial resistance genes, K. pneumoniae isolates with carbapenem resistance often exhibit resistance to other non-β-lactam antimicrobial agents (Temkin et al, 2014). Recent reports showed that sequence type 258 (ST258) is the most prevalent clone contributing to the worldwide spread of KPC-producing K. pneumoniae and is the cause of numerous hospital-associated outbreaks (Kitchel et al, 2009; Hammerum et al, 2010; Marquez et al, 2014). The aim of the present study was to investigate the dissemination of ventilator-associated K. pneumoniae with carbapenem resistance in a tertiary teaching hospital in central China. We demonstrated a outbreak by ventilator-associated ST11 K. pneumoniae with co-production of CTX-M-24 and KPC-2

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call